Recruiting

Observational StudyClinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Sponsor:

Freenome Holdings Inc.

Code:

NCT06122077

Conditions

Lung Cancer Diagnosis

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

blood draw

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Freenome Holdings Inc. on 2025-08-05.